If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
440.00    5.00 (1.15%)
Bid:
430.00
Ask:
440.00
Spread: 10.00 (2.326%)
Market Cap: £175.88m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

Today 07:00

RNS Number : 8729K
Dialight PLC
03 July 2026
 

Dialight plc (the "Company")

Director / PDMR Shareholdings

 

Options under the Dialight Plc 2022 Annual Performance Bonus Plan ("APBP")

 

Dialight plc (LSE: DIA.L), a global leader in sustainable LED lighting for industrial applications, announces that on 2 July 2026, Steve Blair, Group Chief Executive Officer and Mark Fryer, Group Chief Financial Officer, were granted a Deferred Share Award ("Deferred Award") in the form of nil cost options entitling them to receive ordinary shares of 1.89 pence each in the Company in accordance with the rules of the APBP.

 

Name

Number of shares awarded under the APBP

Steve Blair

17,240

Mark Fryer

8,979

 

The Deferred Award will be exercisable in two equal tranches on or after 2 July 2028 and 2 July 2029, subject to continued employment at each date of vesting.

 

No consideration was paid for the grant of these awards and no consideration is due to be paid on the vesting of the awards.

 

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulations, provide further details.

 

Contacts: 

Dialight plc

Tel: +44 (0) 203 058 3525

Laura Walker

LEI: 2138001AD31KKD29Z495

 

 

 

 

 

1.

Details of PDMR / person closely associated:

(a)

Name:

Steve Blair

2.

Reason for the notification:

(a)

Position / status:

CEO

(b)

Initial notification / amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name:

Dialight plc

(b)

LEI:

2138001AD31KKD29Z495

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares

 

GB0033057794

(b)

Nature of the transaction:

Grant of a nil-cost option over 17,240 ordinary shares under the Dialight Plc 2022 Annual Performance Bonus Plan.

(c)

Price (pence):

Volume(s):

 

Volume

Price

17,240

0.00

(d)

Aggregated information:

- Aggregate volume:

- Price (pence):

Not applicable - single transaction

(e)

Date of transaction:

2 July 2026

(f)

Place of transaction:

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated:

(a)

Name:

Mark Fryer

2.

Reason for the notification:

(a)

Position / status:

CFO

(b)

Initial notification / amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name:

Dialight plc

(b)

LEI:

2138001AD31KKD29Z495

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares

 

GB0033057794

(b)

Nature of the transaction:

Grant of a nil-cost option over 8,979 ordinary shares under the Dialight Plc 2022 Annual Performance Bonus Plan.

(c)

Price (pence):

Volume(s):

 

Volume

Price

8,979

0.00

(d)

Aggregated information:

- Aggregate volume:

- Price (pence):

Not applicable - single transaction

(e)

Date of transaction:

2 July 2026

(f)

Place of transaction:

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUBUMUPQGMP
Date   Source Headline
3rd Jul 20267:00 amRNSDirector/PDMR Shareholding
3rd Jul 20267:00 amRNSDirector/PDMR Shareholding
1st Jul 202612:05 pmRNSHolding(s) in Company
29th Jun 202612:39 pmRNSDirector/PDMR Shareholding
29th Jun 20267:00 amRNSDirector/PDMR Shareholding
25th Jun 20269:46 amRNSDirector/PDMR Shareholding
24th Jun 202611:45 amRNSHolding(s) in Company
23rd Jun 20267:00 amRNSFinal Results
10th Jun 20267:30 amRNSDirector Declaration
8th Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.